Screening and Assessment of Hypoglycemic Active Peptide from Natural Edible Pigment Phycobiliprotein Based on Molecular Docking, Network Pharmacology, Enzyme Inhibition Assay Analyses, and Cell Experiments
Marine Drugs · 2025
DOI: 10.3390/md23080331 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Zhimin Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: International Collaborative Research Center for the Development and Utilization of Tropical Food for Special Medical Purpose, School of Public Health…. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Peptides, Phycobiliproteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hainan Provincial Natural Science Foundation of China, Education Department of Hainan Province, Research Start-Up Funds from Hainan Medical University in China.
Abstract (Originalsprache)
Phycobiliproteins have gained increasing attention for their antidiabetic potential, yet the specific bioactive peptides and their targets and molecular mechanisms have remained unclear. In this study, four peptides with potential hypoglycemic activity were identified through virtual screening. Network pharmacology was employed to elucidate their hypoglycemic mechanism in the treatment of T2DM. A subsequent in vitro assay confirmed that the synthesized peptides, GR-5, SA-6, VF-6, and IR-7, exhibited significant inhibitory activity against α-glucosidase and DPP-IV. In insulin-resistant HepG2 models, all four peptides exhibited no cytotoxicity. Among them, GR-5 demonstrated the most promising therapeutic potential by remarkably enhancing cellular glucose consumption capacity. Furthermore, GR-5 administration substantially increased glycogen synthesis and enzymatic activities of hexokinase and pyruvate kinase with statistically significant improvements compared to the control groups. This study provides novel peptide candidates for T2DM treatment and validates an integrative strategy for targeted bioactive peptide discovery, advancing the development of algal protein-based therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- International Collaborative Research Center for the Development and Utilization of Tropical Food for Special Medical Purpose, School of Public Health, Hainan Academy of Medical Sciences, Hainan Medical University, Haiko…
- State Key Laboratory of Marine Resource Utilization in South China Sea, Hainan University, Haikou 570228, China.
ORCID-Profile: Zhimin Zhu, Pengcheng Fu
Förderung
- Hainan Provincial Natural Science Foundation of China
- Education Department of Hainan Province
- Research Start-Up Funds from Hainan Medical University in China
Zitieren
APA
Zhu, Z., Zhang, Y., He, B., He, L., Fang, G., Ning, Y., Fu, P., & Liu, J. (2025). Screening and Assessment of Hypoglycemic Active Peptide from Natural Edible Pigment Phycobiliprotein Based on Molecular Docking, Network Pharmacology, Enzyme Inhibition Assay Analyses, and Cell Experiments. Marine Drugs. https://doi.org/10.3390/md23080331
Vancouver
Zhu Z, Zhang Y, He B, He L, Fang G, Ning Y, et al. Screening and Assessment of Hypoglycemic Active Peptide from Natural Edible Pigment Phycobiliprotein Based on Molecular Docking, Network Pharmacology, Enzyme Inhibition Assay Analyses, and Cell Experiments. Marine Drugs. 2025. doi:10.3390/md23080331
BibTeX
@article{Zhu2025,
author = {Zhu, Zhimin and Zhang, Yan and He, Bingbing and He, Limin and Fang, Guihong and Ning, Yi and Fu, Pengcheng and Liu, Jing},
title = {Screening and Assessment of Hypoglycemic Active Peptide from Natural Edible Pigment Phycobiliprotein Based on Molecular Docking, Network Pharmacology, Enzyme Inhibition Assay Analyses, and Cell Experiments},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23080331}
}
EUVIMED